Market Industry Reports (MIR) has published a new report

New Post Public Reply Private Reply Replies (0) Message Board
sam_7
673
Market Industry Reports (MIR) has published a new report titled “ Monocyte Activation Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” The global Monocyte Activation Test market was valued at over US$ 6.5 Mn. in 2018 and is expected to grow at a double digit CAGR during the forecasted period.

Download Free PDF Sample Copy @ https://www.marketindustryreports.com/pdf/48

The global monocyte activation test market is witnessing continuous advancements in test offerings and extensive growth in the product portfolio of major as well as local manufacturers. The growth of the global monocyte activation test market is attributed to increasing number of pharmaceutical and biotechnology industries globally, rising research and development, increased investments and surge in new drug approval activities. Additionally, a proposed ban on animal tests has resulted in reducing the use of the rabbit for pyrogen test. This is one of the significant factors that is driving the growth of monocyte activation tests globally. Increase in public and regulatory concerns about product safety further support the market growth.
Ban on Animal-based Pyrogen Test by Several Regulatory is likely to Boost Monocyte Activation Tests Market

Animals are used to test both the safety and efficacy of therapeutic drugs, cosmetics, household products, and chemicals. Fortunately there are developing numbers of effective non-animal alternatives that can replace the use of animals in pyrogen testing. Moreover, many countries have regulatory requirements that stipulate a ban on animal based pyrogen testing. There have been major changes in the European Union in recent years. In the EU the use of animals for pyrogen testing of cosmetic products has been banned since 2009, the use of animals for the testing of cosmetic ingredients also has been banned since March 2013. Furthermore, the EU banned the sale of any cosmetics tested on animals from March 2013 onwards. Israel imposed similar cosmetic testing bans in 2007 and 2013, and similar policy change is under consideration in India and South Korea. These factors are anticipated to present a lucrative growth opportunity for the global monocyte activation test market in the coming years.

Browse key industry insights spread across 150 pages with market data tables & figures & charts from the report, Monocyte Activation Test Market by Product (Monocyte Activation Test Kits and Reagents), Source (Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based, and Cell Line Based), Application (Medical Devices, Lipid Parenteral, Dialysis Liquids, Blood Products, and Toxic/immune-modulatory Drugs) and Region - Global Forecast to 2023 - Global Analysis & Forecast, 2019-2030 in detail along with the table of contents: https://www.marketindustryreports.com/48/mono...est-market

Increasing Investments in R&D

Rising prevalence and incidences of several diseases worldwide has triggered the need for advanced R&D scenario across all sectors of biotechnology, pharmaceuticals and research establishments. Both public and private sectors are now focusing on new innovative techniques to obtain latest medical breakthroughs. According to studies, it was estimated that the total spending on R&D by mid-market biotechnology companies, witnessed an increment of approximately 18% between 2015 and 2016. Growing need to address several forms of ailments has been crucial in dictating the funding and R&D spending by government establishments as well as major market players and other research institutes. Increasing R&D investments and spending is anticipated to positively contribute to the growth of the global monocyte activation test market.

Inadequate supply of MAT test kits & reagents to Restrain Global Market

According to WHO (World Health Organization), only 12.5 million blood donations are collected globally, and approximately half of these are collected in high-income countries, which is home to 19% of the world’s population. Thus, inadequate number of healthy blood donors hampers the manufacturing of MAT kits & reagents which eventually effects the growth of the global market. Moreover, there is an increase in application of pyrogen tests in various fields, whereas initially pyrogen test was introduced only for pharmaceutical products. However, presently it is being used on medical devices, implants, purification of water, and food & beverages industries.

Rapid Growth of the Asia Pacific Market

Asia Pacific is estimated to witness the highest CAGR during the forecast period. Increasing growth of the R&D infrastructure, continuously growing economy, and proposed ban of animal-based pyrogen test by many South Asian countries is anticipated to present a lucrative growth scenario for the monocyte activation test market in this region. Furthermore, increasing R&D expenditures in the region is expected to present an attractive growth prospect for the market in the coming years. 

Major Players in the Monocyte Activation Test Market

The prominent players in the global monocyte activation test market are Merck KGaA, Thermo Fisher Scientific, Becton, Dickinson and Company, Sanquin, Charles River Laboratories International, Inc., Microcoat Biotechnologie GmbH, SOLVIAS AG and Lonza Group among others.

Get Exclusive Discount @ https://www.marketindustryreports.com/discount/48

About Market Industry Reports-

Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.

We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.

Contact Us- 


502, Sai Radhe, Kennedy Road,
Behind Hotel Sheraton Grand,
Near Pune Station, Pune 411 001
Email: sales@marketindustryreports.com
Phone: + 91 967353933
Website: https://www.marketindustryreports.com/
Follow Us- LinkedIn | Twitter | Google+ | Facebook

Horizon Pharma Inc. (HZNP) Stock Research Links

HZNP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Celebrating Cultural Excellence: Fukuoka Prize 2025 Laureates Revealed

Updated Category News Views 360

Fukuoka City Announces 2025 Fukuoka Prize Winners Fukuoka City has revealed the recipients of the prestigious Fukuoka Prize for 2025, honoring remarkable individuals in the field of Asian studies and the arts. This award is presented to those who excel in preserving and enhancing the rich tapestry of Asian culture. Fukuoka City is dedicated to celebrating these...

Continue Reading
Investors Unite: Join Flywire Corporation Legal Action Today

Updated Category News Views 168

Flywire Corporation Investors Take Action Against Securities Fraud In a moment of reckoning, investors in Flywire Corporation are seizing the opportunity to join a class action lawsuit concerning alleged securities fraud. The filing of this lawsuit has been initiated to hold accountable those responsible for misleading investors during a specified period, marking a...

Continue Reading
Venus Concept Secures $2.7 Million for Growth and Innovation

Updated Category News Views 323

Venus Concept Raises Significant Funds for Future Endeavors Venus Concept Inc. (NASDAQ: VERO), a renowned name in the global medical aesthetic technology arena, recently achieved a noteworthy milestone by closing a registered direct offering that provided around $1.57 million in gross proceeds. The offering consisted of 386,700 shares of common stock, sold at $4.06 each,...

Continue Reading
Revolutionary RAGE: UPENDS Launches Game-Changing Vape System

Updated Category News Views 211

UPENDS Unveils Groundbreaking Open Pod Vape System In a remarkable stride forward for the vaping industry, UPENDS has launched their revolutionary RAGE open pod system, designed to transform how enthusiasts experience vaping. As the European market continues to evolve, this cutting-edge device positions itself as a leader in user-centric innovation and compliance. The...

Continue Reading
Investors Target Kyverna Therapeutics: Key Details You Need

Updated Category News Views 101

Understanding Ongoing Investigations at Kyverna Therapeutics As the financial landscape continues to evolve, investors find themselves keenly interested in the developments surrounding Kyverna Therapeutics, Inc. (NASDAQ: KYTX). With a prominent law firm engaged in scrutinizing potential claims, the situation promises vital updates for concerned stakeholders. Faruqi &...

Continue Reading